Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Glycosaminoglycan Compositional Analysis of Relevant Tissues in Zika Virus Pathogenesis and in Vitro Evaluation of Heparin as an Antiviral against Zika Virus Infection.

Kim SY, Koetzner CA, Payne AF, Nierode GJ, Yu Y, Wang R, Barr E, Dordick JS, Kramer LD, Zhang F, Linhardt RJ.

Biochemistry. 2019 Feb 26;58(8):1155-1166. doi: 10.1021/acs.biochem.8b01267. Epub 2019 Feb 13.

PMID:
30698412
2.

Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease.

Li Z, Sakamuru S, Huang R, Brecher M, Koetzner CA, Zhang J, Chen H, Qin CF, Zhang QY, Zhou J, Kramer LD, Xia M, Li H.

Antiviral Res. 2018 Feb;150:217-225. doi: 10.1016/j.antiviral.2017.12.018. Epub 2017 Dec 27.

3.

Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction.

Li Z, Brecher M, Deng YQ, Zhang J, Sakamuru S, Liu B, Huang R, Koetzner CA, Allen CA, Jones SA, Chen H, Zhang NN, Tian M, Gao F, Lin Q, Banavali N, Zhou J, Boles N, Xia M, Kramer LD, Qin CF, Li H.

Cell Res. 2017 Aug;27(8):1046-1064. doi: 10.1038/cr.2017.88. Epub 2017 Jul 7.

4.

A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease.

Brecher M, Li Z, Liu B, Zhang J, Koetzner CA, Alifarag A, Jones SA, Lin Q, Kramer LD, Li H.

PLoS Pathog. 2017 May 25;13(5):e1006411. doi: 10.1371/journal.ppat.1006411. eCollection 2017 May.

5.

A key role for the carboxy-terminal tail of the murine coronavirus nucleocapsid protein in coordination of genome packaging.

Kuo L, Koetzner CA, Masters PS.

Virology. 2016 Jul;494:100-7. doi: 10.1016/j.virol.2016.04.009. Epub 2016 Apr 19.

6.

Analyses of Coronavirus Assembly Interactions with Interspecies Membrane and Nucleocapsid Protein Chimeras.

Kuo L, Hurst-Hess KR, Koetzner CA, Masters PS.

J Virol. 2016 Apr 14;90(9):4357-4368. doi: 10.1128/JVI.03212-15. Print 2016 May.

7.

Recognition of the murine coronavirus genomic RNA packaging signal depends on the second RNA-binding domain of the nucleocapsid protein.

Kuo L, Koetzner CA, Hurst KR, Masters PS.

J Virol. 2014 Apr;88(8):4451-65. doi: 10.1128/JVI.03866-13. Epub 2014 Feb 5.

8.
9.

Accessory protein 5a is a major antagonist of the antiviral action of interferon against murine coronavirus.

Koetzner CA, Kuo L, Goebel SJ, Dean AB, Parker MM, Masters PS.

J Virol. 2010 Aug;84(16):8262-74. doi: 10.1128/JVI.00385-10. Epub 2010 Jun 2.

10.

Identification of in vivo-interacting domains of the murine coronavirus nucleocapsid protein.

Hurst KR, Koetzner CA, Masters PS.

J Virol. 2009 Jul;83(14):7221-34. doi: 10.1128/JVI.00440-09. Epub 2009 May 6.

11.

Genetic and molecular biological analysis of protein-protein interactions in coronavirus assembly.

Masters PS, Kuo L, Ye R, Hurst KR, Koetzner CA, Hsue B.

Adv Exp Med Biol. 2006;581:163-73. Review. No abstract available.

PMID:
17037525
12.
13.

Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization.

de Haan CA, Volders H, Koetzner CA, Masters PS, Rottier PJ.

J Virol. 2002 Dec;76(24):12491-502.

14.

Construction of a mouse hepatitis virus recombinant expressing a foreign gene.

Fischer F, Stegen CF, Koetzner CA, Masters PS.

Adv Exp Med Biol. 1998;440:291-5.

PMID:
9782295
15.
16.

A conditional-lethal murine coronavirus mutant that fails to incorporate the spike glycoprotein into assembled virions.

Ricard CS, Koetzner CA, Sturman LS, Masters PS.

Virus Res. 1995 Dec;39(2-3):261-76.

PMID:
8837889
17.

Construction of murine coronavirus mutants containing interspecies chimeric nucleocapsid proteins.

Peng D, Koetzner CA, McMahon T, Zhu Y, Masters PS.

J Virol. 1995 Sep;69(9):5475-84.

20.

Site-directed mutagenesis of the genome of mouse hepatitis virus by targeted RNA recombination.

Masters PS, Koetzner CA, Peng D, Parker MM, Ricard CS, Sturman LS.

Adv Exp Med Biol. 1993;342:143-8.

PMID:
8209721
21.

Supplemental Content

Loading ...
Support Center